Mail

Australia markets open in 6 hours 17 minutes

ALL ORDS
7,269.80
-66.30(-0.90%)
AUD/USD
0.6552
-0.0070(-1.06%)
ASX 200
7,061.60
-63.10(-0.89%)
OIL
73.35
+0.31(+0.42%)
GOLD
2,032.40
-9.80(-0.48%)
Bitcoin AUD
64,946.84
+1,759.59(+2.78%)

FEELING THE PINCH?

Beat the cost-of-living squeeze with our pro tips and helpful hacks - sign up now

Inspire Medical Systems, Inc. (INSP)

NYSE - Nasdaq Real-time price. Currency in USD

Add to watchlist

149.92

-6.28

(-4.02%)

As of 11:43AM EST. Market open.

Currency in USD

Valuation measures⁴

Market cap (intra-day)	4.61B
Enterprise value	4.17B
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	7.99
Price/book (mrq)	8.47
Enterprise value/revenue	7.32
Enterprise value/EBITDA	-142.54

Trading information

Stock price history

Beta (5Y monthly)	1.39
52-week change ³	-32.36%
S&P500 52-week change ³	15.95%
52-week high ³	330.00
52-week low ³	123.27
50-day moving average ³	157.46
200-day moving average ³	240.17

Share statistics

Avg vol (3-month) ³	726.53k
Avg vol (10-day) ³	462.61k
Shares outstanding ⁵	29.52M
Implied shares outstanding ⁶	29.52M
Float ⁸	28.96M
% held by insiders ¹	1.57%
% held by institutions ¹	99.87%
Shares short (14 Nov 2023) ⁴	1.32M
Short ratio (14 Nov 2023) ⁴	1.49
Short % of float (14 Nov 2023) ⁴	5.06%
Short % of shares outstanding (14 Nov 2023) ⁴	4.47%
Shares short (prior month 12 Oct 2023) ⁴	1.17M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	30 Dec 2022
Most-recent quarter (mrq)	29 Sept 2023

Profitability

Profit margin	-5.75%
Operating margin (ttm)	-8.79%

Management effectiveness

Return on assets (ttm)	-5.34%
Return on equity (ttm)	-6.46%

Income statement

Revenue (ttm)	570.19M
Revenue per share (ttm)	19.56
Quarterly revenue growth (yoy)	40.40%
Gross profit (ttm)	341.74M
EBITDA	-47.3M
Net income avi to common (ttm)	-32.77M
Diluted EPS (ttm)	-1.09
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	464.21M
Total cash per share (mrq)	15.72
Total debt (mrq)	25.17M
Total debt/equity (mrq)	4.63%
Current ratio (mrq)	8.14
Book value per share (mrq)	18.51

Cash flow statement

Operating cash flow (ttm)	26.66M
Levered free cash flow (ttm)	12.41M